Sohail Khan: What Comes After IV Thrombolysis
Sohail Khan, Medical Student at Khyber Medical College, shared a post on LinkedIn:
“You have administered intravenous thrombolysis for an acute ischaemic stroke.
When is it safe to initiate antiplatelet therapy?
Major clinical guidelines (AHA/ASA, NICE) recommend withholding antiplatelet agents for 24 hours post-thrombolysis.
Clinical management sequence:
Defer for 24 hours: Hold aspirin, clopidogrel, or parenteral anticoagulants for at least 24 hours following alteplase or tenecteplase infusion.
Early administration significantly increases the risk of symptomatic intracranial haemorrhage.
Follow-up neuroimaging: Obtain a repeat non-contrast CT or MRI brain scan at 24 hours to rule out haemorrhagic transformation.
Initiate antiplatelet therapy: Once post-thrombolysis imaging excludes bleeding, start aspirin (160–300 mg daily).
Special exception: In patients undergoing endovascular thrombectomy who require emergent carotid or intracranial stenting, antiplatelet timing must be individually tailored in consultation with a stroke consultant and neurointerventionalist.
Key takeaway: Always confirm the absence of intracranial haemorrhage on 24-hour follow-up imaging before giving the first dose of aspirin post-thrombolysis.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day